Le Lézard
Classified in: Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

James Hardie Industries To Announce Fourth Quarter And Fiscal Year 2024 Financial Results on 21 May 2024


James Hardie Industries plc (ASX: JHX; NYSE: JHX) will announce financial results, for its fourth quarter and full year ended 31 March 2024, on the ASX before market on Tuesday, 21 May 2024.

The Company will host a conference call that morning at 9:00am Australian Eastern Time (AEST).

For those in North America the conference call will commence at 7:00pm Eastern Time (ET), Monday 20 May.

Once registered, participants will receive a calendar invitation with global dial-in numbers and a unique PIN which will be required to join the call.

A replay of the call will be available shortly after the call and will be available at;
https://ir.jameshardie.com.au/financial-information/financial-results

This media release has been authorized by Mr. Aaron Erter, Chief Executive Officer.

James Hardie Industries plc is a limited liability company incorporated in Ireland with its registered office at 1st Floor, Block A, One Park Place, Upper Hatch Street, Dublin 2, D02 FD79, Ireland


These press releases may also interest you

at 11:30
Strongpoint Partners ("Strongpoint"), a tech-enabled financial services platform focused on third-party administration of retirement plans, recordkeeping, payroll, and HR solutions for SMBs, announced a partnership with Carlson...

at 11:27
FLX Networks, the innovative network revolutionizing the engagement experience between asset and wealth managers, today announced the launch of its Professional Membership, aimed at empowering industry professionals with unparalleled access,...

at 11:25
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. ("Doximity" or "the Company") for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule...

at 11:22
Long Grove Pharmaceuticals continues to meet the critical care needs of hospital pharmacies with the launch of Premix Vasopressin in its most commonly used concentrations....

at 11:17
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. ("Evolv" or "the Company")  for violations of §§10(b) and 20(a)...

at 11:15
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against bluebird bio, Inc. ("bluebird" or "the Company") for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and...



News published on and distributed by: